Evidence map›Paper›PMID 38338436›Full record

ArticleMolecules (Basel, Switzerland)2024

Neuroprotection of Truncated Peptide IIAVE from

Qiuqi Liu, Liyuan Lin, Huijuan Li, Zhong-Ji Qian

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Marine life science & technology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qiuqi LiuSchool of Chemistry and Environment, Guangdong Ocean University, Zhanjiang 524088, China.
Liyuan LinSchool of Chemistry and Environment, Guangdong Ocean University, Zhanjiang 524088, China.
Huijuan LiSchool of Chemistry and Environment, Guangdong Ocean University, Zhanjiang 524088, China.
Zhong-Ji QianSchool of Chemistry and Environment, Guangdong Ocean University, Zhanjiang 524088, China.ORCID 0000-0001-9220-2600
Guangdong Ocean University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder of the elderly for which there is no cure or disease-modifying therapy. Mitochondrial dysfunction and oxidative stress play a central role in dopaminergic neurodegeneration in PD. Therefore, antioxidants are considered a promising neuroprotective approach. In in vivo activity studies, 6-OHDA-induced oxidative stress in SH-SY5Y cells was established as a model of PD for cellular experiments. IIAVE (Ile-Ile-Ala-Val-Glu) was derived from

Indexed as

HaptophytaNeuroblastomaNeuroprotective AgentsParkinson DiseaseAgedAntioxidantsApoptosisCell Line, TumorHumansKelch-Like ECH-Associated Protein 1Molecular Docking SimulationNeuroprotectionNF-E2-Related Factor 2OxidopamineProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesAntioxidantsKelch-Like ECH-Associated Protein 1Neuroprotective AgentsNF-E2-Related Factor 2OxidopamineProto-Oncogene Proteins c-bcl-2Reactive Oxygen Species6-OHDAIsochrysis zhanjiangensismolecular dockingneuroprotectionoxidative stressquantum chemicalSH-SY5Y cells

Identifiers

PMID38338436
PMCPMC10856281
OpenAlexW4391472417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.